𝔖 Bobbio Scriptorium
✦   LIBER   ✦

CD34+ lineage specific donor cell chimerism for the diagnosis and treatment of impending relapse of AML or myelodysplastic syndrome after allo-SCT

✍ Scribed by Rosenow, F; Berkemeier, A; Krug, U; Müller-Tidow, C; Gerss, J; Silling, G; Groth, C; Wieacker, P; Bogdanova, N; Mesters, R; Büchner, T; Kienast, J; Berdel, W E; Stelljes, M

Book ID
120042845
Publisher
Nature Publishing Group
Year
2013
Tongue
English
Weight
360 KB
Volume
48
Category
Article
ISSN
0007-1188

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combining Azacitidine (Vidaza®, Aza) and
Combining Azacitidine (Vidaza®, Aza) and Donor Lymphocyte Infusions (DLI) as First Salvage Treatment in Patients (PTS) With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS) Relapsing After Allogeneic Hematopoietic Stem Cell Transplantation (allo-SCT): Interim-Analysis From the Azarela-Trial (NCT-00795548)
✍ T. Schroeder; A.G. Czibere; N. Kröger; U. Platzbecker; G. Bug; L. Uharek; T. Luf 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 63 KB